51
|
Nguyen T, Auquier MA, Renard C, Cordonnier C, Saint F, Remond A. [Hemoptysis and spontaneous rupture of a primary renal angiosarcoma: a case report]. ACTA ACUST UNITED AC 2011; 91:1313-7. [PMID: 21242919 DOI: 10.1016/s0221-0363(10)70201-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
52
|
Claudon P, Spie R, Bats M, Saint F, Petit J. [Male stress urinary incontinence: medium-term results of treatment by sub-urethral bone anchored sling InVance™]. Prog Urol 2011; 21:625-30. [PMID: 21943659 DOI: 10.1016/j.purol.2011.01.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2010] [Revised: 12/08/2010] [Accepted: 01/11/2011] [Indexed: 11/15/2022]
Abstract
OBJECTIVE To analyze the functional and urodynamic results of a compressive sub-urethral sling with bone anchoring InVance™. METHODS One hundred and six successive patients were operated with this system between August 2004 and March 2009. Urinary incontinence was classified according to the number of daily protections. All the patients have benefited from a clinical, endoscopic and urodynamic pre and post-operative evaluation. The results were classified in four groups, at three months and at one year, according to whether the patients were dry (A), very improved (B), little improved (C), or with no improvement (D). RESULTS The average age of the patients during the installation of the strip was 67.4 years (46-82). At three months, the rate of dry (A) or very improved patients (B) was of 81.2% (A=75.5%; B=5.7%), and at one year: 75.5% (A=61%; B=14.5%). At three months, the rate of patients little improved (C) or not improved (D) was of 18.8% (C=16%; D=2.8%), and at one year: 24.5% (C=20.3%; D=4.2%). These results deteriorated according to the initial rank of incontinence II, III, and I. Six patients (5.7%) were explanted because of a prosthetic infection which perished at an average of 9 months (3-18). Infection was linked to operative time (p=0.02), and patients age. No osteitis nor urethral erosion were noted. There was a significant rise in the pressures of maximum fence at rest and maximum urethral pressures in reserve (p=0.01). At one year, score ICIQ-UI SF decreased overall by 7.1 points. CONCLUSION The medium-term results of under-urethral supporting with bone anchoring InVance™ are very encouraging. This technique presents an acceptable morbidity and a good tolerance. It can be proposed in first intention for a urinary incontinence whatever the rank is, even if the effectiveness is particularly present in incontinences of rank I and II.
Collapse
|
53
|
Spinoit AF, Petit T, Elalouf V, Saint F, Petit J. [Signet-ring cell primitive bladder carcinoma: a rare and aggressive tumor]. Prog Urol 2011; 21:651-3. [PMID: 21943663 DOI: 10.1016/j.purol.2011.01.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2010] [Revised: 12/28/2010] [Accepted: 01/09/2011] [Indexed: 10/18/2022]
Abstract
We report the case of a single patient suffering of a primary signet-ring cell carcinoma of the urinary bladder. This histological subtype of primary bladder cancer is very rare. We thus want to emphasize on its pathological specificity in order to improve the postoperative strategic treatment, knowing it is a rare but very aggressive kind of tumor.
Collapse
|
54
|
Elalouf V, Vandwalle J, Viart L, Petit J, Saint F. [Renal colic "ischemic" of renal infarction: A plea for routine helical CT in emergency]. Prog Urol 2011; 21:184-90. [PMID: 21354036 DOI: 10.1016/j.purol.2010.08.052] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2009] [Revised: 08/18/2010] [Accepted: 08/22/2010] [Indexed: 10/18/2022]
Abstract
OBJECTIVES Through a retrospective cohort, to analyse causative factors of acute renal infarction and specific therapeutic. Recall the need to carry a computerised tomoraphy (CT) in any flank pain suggestive of renal colic can hide a renal infarct. METHOD Over a period of 24 months (2008-2009), we have compiled six patients admitted for acute lumbar pain reported in renal colic and showing a renal infarction. We report the risk factors for cardiovascular disease, the clinical presentation, and the interest of heparin therapy started early in the recovery of renal function. We emphasise the need for abdominal-pelvic CT in emergency before a renal colic pain associated with injection of contrast medium if no stone obstacle is identified. RESULTS Five patients had risk factors for cardiovascular disease including one personal history of deep vein thrombosis and pulmonary embolism and two, a family history of myocardial infarction. Five patients were treated early with LMWH, and for one the herapin was started at 72 hours of onset of symptoms. In all cases, no effect on renal function was noted. CONCLUSION Renal infarction is a rare but probably underestimated, occurring on land known cardiovascular often. The abdominopelvic CT without injection is increasingly practiced in front of abdominal pain syndromes, it seems imperative to complete the review by the injection of contrast material if stone obstruction is unconfirmed. Early management by herapin appears to improve the complete recovery of renal function.
Collapse
|
55
|
Spie R, Claudon P, Raynal G, Saint F, Petit J. [Radiotherapy influence, about results of the InVance(®) male sling in men with stress urinary incontinence]. Prog Urol 2011; 21:549-53. [PMID: 21872158 DOI: 10.1016/j.purol.2010.11.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2010] [Revised: 11/07/2010] [Accepted: 11/21/2010] [Indexed: 11/17/2022]
Abstract
AIMS To study impact of previous radiotherapy on urodynamic parameters, continence and complication rate, after prosthetic implantation with InVance® device. PATIENTS AND METHODS We included 106 patients between August 2004 and March 2009. We stratified urinary incontinence according to pads daily used, in grade I (one to two pads), II (three to four), or III (more than four or condom catheter use). We compared one group of 24 patients with previous radiotherapy (R) to 82 control patients (T) without one. Follow-up was made at three and six postoperative months and then annually. Results were classified into: no leaks, improved or failure. RESULTS Mean follow-up was 14.8 months (median=12.8) in group R and 12.4 months (median=8.8) in group T. At three postoperative months, continence was achieved in 62.5% patients from group R and in 77% patients in group T (P: ns). At 12 months, results on continence were respectively 52.6% in group R and 63.2% in group T (P: ns). Six patients were explanted because of an infection (5.7%), among which two in group R (8.3%) and four in group T (4.8%). Infection was significantly linked to operative time (P: 0.02). CONCLUSION Previous radiotherapy has no impact on urodynamic parameters and continence, on short- and mid-term analysis, after implantation of a bone-anchored suburethral sling with InVance® device, preferentially patients with mild to moderate incontinenec urinary.
Collapse
|
56
|
Saint F, Quintens H, Roupret M, Amsellem-Ouazana D, Mazerolles C, Wallerand H, Bernardini S, Guy L, Soulié M, Pfister C. [Diagnostic test for bladder cancer: the NMP22®]. Prog Urol 2011; 21:245-9. [PMID: 21482397 DOI: 10.1016/j.purol.2010.09.027] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2010] [Revised: 08/30/2010] [Accepted: 09/04/2010] [Indexed: 10/18/2022]
Abstract
INTRODUCTION Diagnosis and follow-up of bladder cancer is based on cytology and cystoscopic exams. Cytology is highly specific but remains with a highly variable sensitivity. Cystoscopy is an invasive exam and has shown specific limits. Urinary test, highly specific and highly sensitive, might be ideal to replace the couple cytology-cystoscopy. MATERIAL AND METHODS Through a literature review, using MeSH system and Pubmed system (keywords: NMP22 and bladder cancer), authors pointed to the value of NMP22 to replace cystoscopy and cytology. RESULTS Between 1996 and 2010, 193 publications were identified with these keywords. Seventeen original articles have been selected based on their quality and methodology. NMP22 was more sensitive than cytology for follow-up and screening of bladder cancer. As screening test, NMP22 has shown positive predictive value between 0 and 70%. As follow-up test, NMP22 has shown more stable positive predictive value close to 70%. Coupled to cytology, NMP22 has shown predictive positive value up to 90%. CONCLUSION For screening test, NMP22 should be the referent test for best selection cases (tobacco, hematuria) and for systemic elimination of false positive cases (ureteral stent, lithiasis). For follow-up test, NMP22-cytology should be the new reference. Moreover, when NMP22 is positive with negative cystoscopy, follow-up may be carefully proposed (recurrence risk×10).
Collapse
|
57
|
Saint F, Elalouf V, Spie R, Cordonnier C, Sevestre H, Petit J. Évaluation prospective monocentrique du ciblage diagnostique par hexaminolevulinate (Hexvix®) des tumeurs urothéliales de vessie : étude préliminaire. Prog Urol 2010; 20:644-50. [DOI: 10.1016/j.purol.2010.04.007] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2009] [Revised: 04/13/2010] [Accepted: 04/21/2010] [Indexed: 10/19/2022]
|
58
|
Vandwalle J, Spie R, Jarry G, Agaesse V, Petit J, Saint F. Phéochromocytome et défaillance cardiaque : une indication exceptionnelle de surrénalectomie en urgence ou semi-urgence. Prog Urol 2010; 20:498-502. [DOI: 10.1016/j.purol.2010.01.011] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2009] [Revised: 01/06/2010] [Accepted: 01/16/2010] [Indexed: 11/24/2022]
|
59
|
Surga N, Makdassi R, Choukroun G, Vandwalle J, Petit J, Saint F. [Adrenal hemorrhage acutised by adrenocorticotropin hormone]. Prog Urol 2010; 20:425-9. [PMID: 20538206 DOI: 10.1016/j.purol.2009.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2009] [Revised: 12/15/2009] [Accepted: 12/22/2009] [Indexed: 10/19/2022]
Abstract
OBJECTIVE Many spontaneous adrenal hematomas have been observed in patients being treated by Synacthène. The purpose of this study is to define how to take those patients in charge on a short-, mid- and long-term. PATIENTS AND METHODS From January 2000 to December 2008, five patients (four males and one female), mean age 47, were taken in charge in our service for spontaneous adrenal hematomas. All those patients had been treated with Synacthène for a mid-sciatic pain for 72 hours. We associated a clinical, endocrine and radiologic staging to treat those patients. RESULTS Four patients underwent a watchful waiting, only one patient needed surgery. No adrenal tumor was ever found during the mean two years follow-up (one to four). Two patients suffered of the condition of the antiphospholipid syndrome. CONCLUSION Spontaneous adrenal hematomas are a most uncommon pathology. The clinical attitude has thus to be defined clearly. The patient must be under close clinical evaluation. Biological and morphological parameters have to be often repeated. An adrenal tumor has to be excluded by the evaluation, as that tumor could be secreting or could not be secreting. Antiphospholipid syndrome must also be excluded.
Collapse
|
60
|
Rouprêt M, Wallerand H, Traxer O, Roy C, Mazerolles C, Saint F, Quintens H, Amsellem-Ouazana D, Bernardini S, Guy L, Soulié M, Pfister C. Bilan et prise en charge d’une tumeur de la voie excrétrice urinaire supérieure en 2010 : mise au point du comité de cancérologie de l’Association francaise d’urologie. Prog Urol 2010; 20:260-71. [DOI: 10.1016/j.purol.2010.01.008] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2010] [Revised: 01/22/2010] [Accepted: 01/25/2010] [Indexed: 10/19/2022]
|
61
|
Amsellem-Ouazana D, Theodore C, Irani J, Bernardini S, Bonnal JL, Chauvet B, Colombel M, Davin JL, Laurent G, Lebret T, Maidenberg M, Mazerolles C, Pfister C, Roupret M, Roy C, Rozet F, Saint F, Soulié M, Guillotreau J. Avancées et synthèse des derniers congrès : ASCO-GU, EAU, AUA, ASCO concernant la prise en charge médicale des cancers urothéliaux. Prog Urol 2010; 20 Suppl 1:S38-40. [DOI: 10.1016/s1166-7087(10)70024-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
62
|
Tillou X, Raynal G, Demailly M, Hakami F, Saint F, Petit J. Endoscopic Management of Urologic Complications Following Renal Transplantation: Impact of Ureteral Anastomosis. Transplant Proc 2009; 41:3317-9. [DOI: 10.1016/j.transproceed.2009.08.046] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
63
|
De Sousa P, Viart L, Petit J, Saint F. [Chylous ascites after trans-peritoneal laparoscopic adrenalectomy: anatomical distribution of lymph nodes and management]. Prog Urol 2009; 20:385-8. [PMID: 20471585 DOI: 10.1016/j.purol.2009.07.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2009] [Revised: 07/07/2009] [Accepted: 07/08/2009] [Indexed: 11/15/2022]
Abstract
We report the case of a chylous ascites after transperitoneal laparoscopic adrenalectomy. This complication is known after surgery in urology but remains rare and was not described after laparoscopic adrenalectomy. Anatomy for lymph nodes distribution was described to understand the occurrence of this complication. The diagnosis of chylous ascites is referred to clinical signs of peritoneal irritation and confirmed by puncture, the treatment is initially conservative.
Collapse
|
64
|
Sénéchal C, Saint F, Petit T, Petit J. [Non-Hodgkin's primitive lymphoma of the testis: long-term prognosis associated with treatment combining systemic and intrathecal chemotherapy]. Prog Urol 2009; 19:209-14. [PMID: 19268261 DOI: 10.1016/j.purol.2008.11.011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2008] [Revised: 11/18/2008] [Accepted: 11/24/2008] [Indexed: 11/17/2022]
Abstract
OBJECTIVES To evaluate the long-term prognosis of a retrospective series of primitive malignant non-Hodgkin's lymphoma (MNHL) of the testicle treated by orchidectomy and combined systemic and intrathecal chemotherapy. PATIENTS AND METHODS From 1992 to 2006, eight consecutive patients were treated for a primitive MNHL of the testicle (stages : IA [n=1], IEA [n=5], IIEA [n=1], IVEA [n=1]) and retrospectively analyzed. All of these tumors were highly malignant. The average age of the patients at the time of diagnosis was 64 years old (46-78). All the patients benefited from an enlarged orchidectomy and received a combination of systemic and intrathecal CHOP and VACP chemotherapy. Six patients finished with some locoregional radiotherapy and three had cerebral radiotherapy. RESULTS Patients were treated over an average period of 90.5 months (12 to 168 months). Five patients (62.5%) responded successfully, one patient had a cerebral relapse stabilized by a second course of chemotherapy. Three patients died, one from septic shock during chemotherapy (IVEA stage), another from mesenteric infarction (IAE stage) and the third from acute coronary thrombosis while in complete remission. CONCLUSION In spite of a reputedly bleak prognosis, primitive MNHL of the testicle treated with a combination of systemic and intrathecal chemotherapy would seem to be associated with a good specific long-term survival. Unfortunately, the rate of mortality linked to chemotherapy is significant (close to 12.5% in our series) and would not appear to entirely protect against cerebral recurrence.
Collapse
|
65
|
Tillou X, Raynal G, Limani K, Saint F, Petit J. Carcinome in situ vésical et urétral chez un patient transplanté rénal : échec de la BCG thérapie. Prog Urol 2008; 18:1097-9. [DOI: 10.1016/j.purol.2008.08.002] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2008] [Revised: 08/06/2008] [Accepted: 08/11/2008] [Indexed: 10/21/2022]
|
66
|
Djeffal C, Fourmarier M, Bracq A, Saint F, Petit J. La taille tumorale : critère prédictif des variations hémodynamiques peropératoires dans la chirurgie du phéochromocytome surrénalien. Prog Urol 2008; 18:507-11. [DOI: 10.1016/j.purol.2008.03.033] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2007] [Accepted: 03/25/2008] [Indexed: 10/22/2022]
|
67
|
Tillou X, Grardel E, Fourmarier M, Bernasconi T, Demailly M, Hakami F, Saint F, Petit J. L’IRM permet-elle de distinguer les tumeurs urothéliales vésicales superficielles et infiltrantes ? Prog Urol 2008; 18:440-4. [DOI: 10.1016/j.purol.2008.04.019] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2007] [Revised: 04/22/2008] [Accepted: 04/23/2008] [Indexed: 10/22/2022]
|
68
|
Bracq A, Fourmarier M, Dugardin F, Saint F, Petit J. [Laparoscopy technical tip: inexpensive scope holder]. Prog Urol 2008; 18:323-6. [PMID: 18538279 DOI: 10.1016/j.purol.2008.03.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2008] [Revised: 03/10/2008] [Accepted: 03/11/2008] [Indexed: 11/28/2022]
Abstract
The authors have created a reproducible laparoscope holder that is 150 euros less expensive, which can be used to perform laparoscopic radical prostatectomy and sacral colpopexy with a single assistant and four free hands. One hundred and sixteen procedures were performed with this original, compact and easy to use apparatus. The characteristics of this scope holder allow mobilization of the camera in three dimensions and maintenance of a fixed image after positioning. This laparoscope holder provides an economic solution that can be used in all laparoscopy units and which liberates the assistant's two hands.
Collapse
|
69
|
Raynal G, Bellan J, Saint F, Tillou X, Petit J. [Ureter drugs]. Prog Urol 2008; 18:152-9. [PMID: 18472067 DOI: 10.1016/j.purol.2008.02.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2007] [Accepted: 02/15/2008] [Indexed: 11/28/2022]
Abstract
Many improvements have been made recently in the field of the ureteral smooth muscle pharmacology. After a brief summary on physiological basis, we review what is known about effects on ureter of different drugs class. In a second part, we review clinical applications for renal colic analgesia, calculi expulsive medical therapy, ESWL adjuvant treatment and preoperative treatment before retrograde access. There are now sufficient data on NSAID and alpha-blockers. beta-agonists, especially for beta3 selective ones, and topical drugs before retrograde access are interesting and should be further evaluated.
Collapse
|
70
|
|
71
|
Rischmann P, Colombel M, Saint F, Malavaud B, Chopin D. 868Prophylactic ofloxacine to improve tolerance of BCG intravesical instillations: A randomised prospective, double-blind, placebo-controlled, multicentre study in patients with mid to high risk superficial bladder tumours. ACTA ACUST UNITED AC 2005. [DOI: 10.1016/s1569-9056(05)80872-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
72
|
Salomon L, Levrel O, Anastasiadis AG, Saint F, de La Taille A, Cicco A, Vordos D, Hoznek A, Chopin D, Abbou CC. Outcome and complications of radical prostatectomy in patients with PSA <10 ng/ml: comparison between the retropubic, perineal and laparoscopic approach. Prostate Cancer Prostatic Dis 2003; 5:285-90. [PMID: 12627213 DOI: 10.1038/sj.pcan.4500605] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2002] [Revised: 04/30/2002] [Accepted: 05/06/2002] [Indexed: 11/09/2022]
Abstract
The objective of this work was to evaluate the oncological outcomes and complications of prostate cancer patients with prostate specific antigen (PSA)<10 ng/ml after radical prostatectomy by retropubic, perineal and laparoscopic approach. From 1988 to 2001, 306 patients with PSA<10 ng/ml underwent radical prostatectomy by the retropubic, perineal or laparoscopic approach. Mean operative time, complication rates, length of hospital stay, catheterization time and pathological results were reviewed. Kaplan-Meier analysis was used to evaluate the likelihood of biochemical PSA recurrence. There were no statistical differences between the three groups in terms of preoperative characteristics except for PSA levels (5.5, 6.5 and 6.6 ng/ml for the retropubic, perineal, and laparoscopic approach, respectively, P<0.05) and for the T1c stage prevalence (50%, 43.1% and 68.4%, P<0.05). Operating time was significatively longer in the laparoscopic approach (266 min), whereas transfusion rate (22.1%), bladder catetherization (12.1 days), and length of hospital stay (12.1 days) were higher in the retropubic group (P<0.05). The percentage of medical and surgical complications were 6.9%, 3.1% and 3.4% (P<0.05) and 18.6%, 16.9% and 11.6% (P<0.05) for the retropubic, perineal, and laparoscopic approach, respectively. Pathological staging revealed pT2 in 76.7%, 78.4% and 81.3% for retropubic, perineal and laparoscopic approach, respectively (P<0.05). Positive surgical positive margins were noted in 20.9%, 18.4% and 20.6% (P>0.05). The actuarial 3-year recurrence-free survival rate was 89.3%, 89.2% and 86.2% (P>0.05) for retropubic, perineal and laparoscopic approach, respectively. It can be concluded that in patients with preoperative PSA<10 ng/ml, clinical outcome and complication rates were similar, regardless of the choice of surgical approach.
Collapse
|
73
|
Rabii R, Salomon L, Hodznek A, Saint F, Cicco A, Chopin DK, Abbou CC. [Prostatic adenocarcinoma revealed by disseminated intravascular coagulation and fibrinolysis]. ANNALES D'UROLOGIE 2002; 36:269-71. [PMID: 12162193 DOI: 10.1016/s0003-4401(02)00108-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Abstract
Disseminated intravascular coagulation (DIC) revealing a prostatic adenocarcinoma is rare. Most of the case are limited to biological abnormalities. We report a case of a 73 year old man with metastatic prostatic carcinoma and CIVD. The patient consulted for epistaxis and ecchymosis with thrombocytopenia and low coagulate factors. The prostatic specific antigen was 2200 ng/ml and fine needle aspiration of bone marrow biopsy detected metastatic cells. The patients received hormonotherapy, heparine and antithrombine III with a good follow up. About this case, we discuss the management of the patient with metastatic prostatic cancer and CIVD.
Collapse
|
74
|
Rabii R, Saint F, Salomon L, Hoznek A, Chopin DK, Abbou CC. [Arterial reconstruction with detubulated aortic patch in simultaneous kidney-pancreas transplantation]. ANNALES D'UROLOGIE 2002; 36:168-70. [PMID: 12056088 DOI: 10.1016/s0003-4401(02)00094-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
Simultaneous pancreas kidney transplantation has become an accepted therapy for the treatment of patients with insulino-dependant diabetes and renal chronic failure. The arterial arrangement of the pancreatic graft is necessary in order to avoid surgical complications of vascular thrombosis. We reported three cases of simultaneous pancreas kidney, a simple procedure using aortic arterial patch preleved with the superior mesenteric artery and detubulated, than the splenic artery is directly anastomosed to the patch.
Collapse
|
75
|
Saint F, Salomon L, Quintela R, Cicco A, Abbou CC, Chopin DK. [Classification, favorable characteristics, prevention and treatment of adverse side-effects associated with Bacillus Calmette-Guerin in the treatment of superficial bladder cancer]. ANNALES D'UROLOGIE 2002; 36:120-31. [PMID: 11969046 DOI: 10.1016/s0003-4401(01)00085-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
The efficacy of Bacillus Calmette-Guérin (BCG) in the treatment of superficial bladder cancer was first reported by Morales in 1976. Several authors have since demonstrated the efficacy of BCG in the prophylaxis and treatment of high-risk superficial bladder tumors (pT1G3, CIS). Although BCG is now recommended as an adjunctive treatment for superficial bladder tumors, the optimal treatment schedule remains to be defined. Results reported by Lamm suggest that an initial induction cycle of six weekly intravesical BCG instillations is suboptimal unless maintenance therapy (three consecutive weekly instillations) is given 3, 6, 12, 18, 24, 30 and 36 months later. However, the use of maintenance therapy is hindered by troublesome adverse reactions. This article reviews adverse reactions associated with BCG treatment, proposed a classification and discusses their prevention and treatment.
Collapse
|